価格表

在庫・価格 : 2025年04月26日 23時22分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Human IL-33 Quantikine ELISA Kit
データシート※最新のデータシートでない場合があります
D3300B RSDアールアンドディー システムズ
R&D Systems, Inc.
1 kit ¥116,000 3個以上 追加

在庫・価格 : 2025年04月26日 23時22分 現在

Human IL-33 Quantikine ELISA Kit

  • 商品コード:D3300B
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥116,000
  • 在庫:3個以上
使用文献
No. 文献情報 備考 参照
1 Maddur MS et al. Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy. J Neuroinflammation 2017 Mar;14(1):58
Maddur MS et al
2017/01/01
Species: Human PubMed
2 Timoteo RP et al. Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris. Mediators Inflamm. 2017;2017:7151285
Timoteo RP et al
2017/01/01
Species: Human PubMed
3 Guerrero CD et al. High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue. Cytokine 2013 Mar;61(3):766-71
Guerrero CD et al
2013/01/01
Species: Human PubMed
4 La Rosa F et al. Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer's Disease. Sci Rep 2017 Dec;7(1):16760
La Rosa F et al
2017/01/01
Species: Human PubMed
5 Lee JU et al. Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis. BMC Pulm Med 2017 Feb;17(1):39
Lee JU et al
2017/01/01
Species: Human PubMed
6 Rivi竪re E et al. Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis. Arthritis Res. Ther. 2018 Jun;20(1):122
Rivi竪re E et al
2018/01/01
Species: Human PubMed
7 Cottagiri M et al. In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity. Cell. Mol. Immunol. 2018 Jul;
Cottagiri M et al
2018/01/01
PubMed
8 Watanabe M et al. Serum sST2 levels predict severe exacerbation of asthma. Respir. Res. 2018 Sep;19(1):169
Watanabe M et al
2018/01/01
PubMed
9 Bu X et al. IL-33 reflects dynamics of disease activity in patients with autoimmune hemolytic anemia by regulating autoantibody production. J Transl Med 2015;13:381
Bu X et al
2015/01/01
PubMed
10 Ketelaar ME et al. The challenge of measuring IL-33 in serum using commercial ELISA: lessons from asthma. Clin. Exp. Allergy 2016 Jun;46(6):884-7
Ketelaar ME et al
2016/01/01
PubMed
11 Wei ZH et al. Genetic variants in IL-33/ST2 pathway with the susceptibility to hepatocellular carcinoma in a Chinese population. Cytokine 2018 Apr;
Wei ZH et al
2018/01/01
PubMed
12 Shen J et al. Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2. Sci Rep 2016 Aug;6:32116
Shen J et al
2016/01/01
PubMed
13 Borsky P et al. Alarmins HMGB1, IL-33, S100A7, and S100A12 in Psoriasis Vulgaris. Mediators Inflamm 2020;2020:8465083
Borsky P et al
2020/01/01
PubMed
14 Han MW et al. Serum IL-1β can be a biomarker in children with severe persistent allergic rhinitis. Allergy Asthma Clin Immunol 2019;15:58
Han MW et al
2019/01/01
PubMed
15 Tanosaki T et al. Clinical characteristics of patients with not well-controlled severe asthma in Japan: Analysis of the Keio Severe Asthma Research Program in Japanese population (KEIO-SARP) registry. Allergol Int 2021 Jan;70(1):61-67
Tanosaki T et al
2021/01/01
Species: Human PubMed
16 Mado H et al. Plasma Interleukin-33 level in relapsing-remitting multiple sclerosis. Is it negatively correlated with central nervous system lesions in patients with mild disability? Clin Neurol Neurosurg 2021 Jul;206:106700
Mado H et al
2021/01/01
Species: Human PubMed
17 Zhuang YG et al. High plasma levels of pro-inflammatory factors interleukin-17 and interleukin-23 are associated with poor outcome of cardiac-arrest patients: a single center experience. BMC Cardiovasc Disord 2020 04;20(1):170
Zhuang YG et al
2020/01/01
Species: Human PubMed
18 Zhou W et al. COX Inhibition Increases <i>Alternaria</i>-Induced Pulmonary Group 2 Innate Lymphoid Cell Responses and IL-33 Release in Mice. J Immunol 2020 08;205(4):1157-1166
Zhou W et al
2020/01/01
Species: Human PubMed
  • No.: 1
  • 文献情報:
    Maddur MS et al. Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy. J Neuroinflammation 2017 Mar;14(1):58
    Maddur MS et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Timoteo RP et al. Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris. Mediators Inflamm. 2017;2017:7151285
    Timoteo RP et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Guerrero CD et al. High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue. Cytokine 2013 Mar;61(3):766-71
    Guerrero CD et al
    2013/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    La Rosa F et al. Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer&#39;s Disease. Sci Rep 2017 Dec;7(1):16760
    La Rosa F et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Lee JU et al. Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis. BMC Pulm Med 2017 Feb;17(1):39
    Lee JU et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Rivi竪re E et al. Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis. Arthritis Res. Ther. 2018 Jun;20(1):122
    Rivi竪re E et al
    2018/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Cottagiri M et al. In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity. Cell. Mol. Immunol. 2018 Jul;
    Cottagiri M et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Watanabe M et al. Serum sST2 levels predict severe exacerbation of asthma. Respir. Res. 2018 Sep;19(1):169
    Watanabe M et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Bu X et al. IL-33 reflects dynamics of disease activity in patients with autoimmune hemolytic anemia by regulating autoantibody production. J Transl Med 2015;13:381
    Bu X et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Ketelaar ME et al. The challenge of measuring IL-33 in serum using commercial ELISA: lessons from asthma. Clin. Exp. Allergy 2016 Jun;46(6):884-7
    Ketelaar ME et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Wei ZH et al. Genetic variants in IL-33/ST2 pathway with the susceptibility to hepatocellular carcinoma in a Chinese population. Cytokine 2018 Apr;
    Wei ZH et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Shen J et al. Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2. Sci Rep 2016 Aug;6:32116
    Shen J et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Borsky P et al. Alarmins HMGB1, IL-33, S100A7, and S100A12 in Psoriasis Vulgaris. Mediators Inflamm 2020;2020:8465083
    Borsky P et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Han MW et al. Serum IL-1&#x3B2; can be a biomarker in children with severe persistent allergic rhinitis. Allergy Asthma Clin Immunol 2019;15:58
    Han MW et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Tanosaki T et al. Clinical characteristics of patients with not well-controlled severe asthma in Japan: Analysis of the Keio Severe Asthma Research Program in Japanese population (KEIO-SARP) registry. Allergol Int 2021 Jan;70(1):61-67
    Tanosaki T et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Mado H et al. Plasma Interleukin-33 level in relapsing-remitting multiple sclerosis. Is it negatively correlated with central nervous system lesions in patients with mild disability? Clin Neurol Neurosurg 2021 Jul;206:106700
    Mado H et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Zhuang YG et al. High plasma levels of pro-inflammatory factors interleukin-17 and interleukin-23 are associated with poor outcome of cardiac-arrest patients: a single center experience. BMC Cardiovasc Disord 2020 04;20(1):170
    Zhuang YG et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Zhou W et al. COX Inhibition Increases <i>Alternaria</i>-Induced Pulmonary Group 2 Innate Lymphoid Cell Responses and IL-33 Release in Mice. J Immunol 2020 08;205(4):1157-1166
    Zhou W et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed